Effect of nicotine and cocaine on neurofilaments and receptors in whole brain tissue and synaptoneurosome preparations

Brain Research Bulletin

Volumn 82, Issue 1-2, 2010, Pages 109-117

  Kovacs, K ^a   Lajtha, A ^a   Sershen, H ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Actin; Alpha 7 nicotinic receptor; Cocaine; Dopamine D1 receptor; Neurofilaments; Nicotine; NMDA NR1 receptor

Indexed keywords

ACTIN; ALPHA 7 NICOTINIC RECEPTOR; COCAINE; CYTOSKELETON PROTEIN; DOPAMINE 1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NEUROFILAMENT H PROTEIN; NEUROFILAMENT L PROTEIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; NEUROTRANSMITTER; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN LEVEL; BRAIN REGION; BRAIN TISSUE; C57BL 6 MOUSE; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; MALE; MOUSE; NEUROFILAMENT; NEUROSYNAPTOSOME; NONHUMAN; PRIORITY JOURNAL; SYNAPSE; WESTERN BLOTTING;

ANIMALS; BRAIN; COCAINE; CYTOSKELETON; DOPAMINE UPTAKE INHIBITORS; GANGLIONIC STIMULANTS; INTERMEDIATE FILAMENT PROTEINS; MALE; MICE; MICE, INBRED C57BL; NICOTINE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SYNAPTOSOMES;

EID: 77952321167     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.02.008     Document Type: Article

References (49)

1. Beitner-Johnson D., Guitart X., Nestler E.J. Common intracellular actions of chronic morphine and cocaine in dopaminergic brain reward regions. Ann. N. Y. Acad. Sci. 1992, 654:70-87.
2. Beitner-Johnson D., Guitart X., Nestler E.J. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 1992, 12:2165-2176.
3. Beneyto M., Meador-Woodruff J.H. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 2008, 33:2175-2186.
4. Bunnemann B., Terron A., Zantedeschi V., Merlo P.E., Chiamulera C. Chronic nicotine treatment decreases neurofilament immunoreactivity in the rat ventral tegmental area. Eur. J. Pharmacol. 2000, 393:249-253.
5. Carboni E., Silvagni A., Rolando M.T., Di C.G. Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J. Neurosci. 2000, 20:RC102.
6. Dermitzaki E., Gravanis A., Venihaki M., Stournaras C., Margioris A.N. Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments. Endocrinology 2001, 142:2022-2031.
7. Dosemeci A., Makusky A.J., Jankowska-Stephens E., Yang X., Slotta D.J., Markey S.P. Composition of the synaptic PSD-95 complex. Mol. Cell Proteomics 2007, 6:1749-1760.
8. Dumartin B., Caille I., Gonon F., Bloch B. Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J. Neurosci. 1998, 18:1650-1661.
9. Ehlers M.D., Fung E.T., O'Brien R.J., Huganir R.L. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J. Neurosci. 1998, 18:720-730.
10. Elder G.A., Friedrich V.L., Kang C., Bosco P., Gourov A., Tu P.H., Zhang B., Lee V.M., Lazzarini R.A. Requirement of heavy neurofilament subunit in the development of axons with large calibers. J. Cell Biol. 1998, 143:195-205.
11. Elder G.A., Friedrich V.L., Bosco P., Kang C., Gourov A., Tu P.H., Lee V.M., Lazzarini R.A. Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content. J. Cell Biol. 1998, 141:727-739.
12. Fallon S., Shearman E., Sershen H., Lajtha A. The effects of glutamate and GABA receptor antagonists on nicotine-induced neurotransmitter changes in cognitive areas. Neurochem. Res. 2007, 32:535-553.
13. Fiumelli H., Riederer I.M., Martin J.L., Riederer B.M. Phosphorylation of neurofilament subunit NF-M is regulated by activation of NMDA receptors and modulates cytoskeleton stability and neuronal shape. Cell Motil. Cytoskeleton 2008, 65:495-504.
14. Garcia-Sevilla J.A., Ventayol P., Busquets X., La H.R., Walzer C., Guimon J. Marked decrease of immunolabelled 68kDa neurofilament (NF-L) proteins in brains of opiate addicts. Neuroreport 1997, 8:1561-1565.
15. Ghasemzadeh M.B., Vasudevan P., Mueller C., Seubert C., Mantsch J.R. Neuroadaptations in the cellular and postsynaptic group 1 metabotropic glutamate receptor mGluR5 and Homer proteins following extinction of cocaine self-administration. Neurosci. Lett. 2009, 452:167-171.
16. Ghasemzadeh M.B., Mueller C., Vasudevan P. Behavioral sensitization to cocaine is associated with increased glutamate receptor trafficking to the postsynaptic density after extended withdrawal period. Neuroscience 2009, 159:414-426.
17. Guitart X., Beitner-Johnson D., Marby D.W., Kosten T.A., Nestler E.J. Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system. Synapse 1992, 12:242-253.
18. Guitart X., Lumeng L., Li T.K., Nestler E.J. Alcohol-preferring and nonpreferring rats display different levels of neurofilament proteins in the ventral tegmental area. Alcohol. Clin. Exp. Res. 1993, 17:580-585.
19. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35:4-26.
20. Harsing L.G., Sershen H., Lajtha A. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization. J. Neurochem. 1992, 59:48-54.
21. Hope B.T., Crombag H.S., Jedynak J.P., Wise R.A. Neuroadaptations of total levels of adenylate cyclase, protein kinase A, tyrosine hydroxylase, CDK5 and neurofilaments in the nucleus accumbens and ventral tegmental area do not correlate with expression of sensitized or tolerant locomotor responses to cocaine. J. Neurochem. 2005, 92:536-545.
22. Kim O.J., Ariano M.A., Lazzarini R.A., Levine M.S., Sibley D.R. Neurofilament-M interacts with the D1 dopamine receptor to regulate cell surface expression and desensitization. J. Neurosci. 2002, 22:5920-5930.
23. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
24. Kristiansen L.V., Beneyto M., Haroutunian V., Meador-Woodruff J.H. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol. Psychiatry 2006, 11. 737-747, 705.
25. A. Lajtha, H. Sershen, Heterogeneity of reward mechanisms, Neurochem. Res. (2009) PM:20012687, in press.
26. Lapin E.P., Maker H.S., Sershen H., Lajtha A. Action of nicotine on accumbens dopamine and attenuation with repeated administration. Eur. J. Pharmacol. 1989, 160:53-59.
27. Lavaur J., Mineur Y.S., Picciotto M.R. The membrane cytoskeletal protein adducin is phosphorylated by protein kinase C in D1 neurons of the nucleus accumbens and dorsal striatum following cocaine administration. J. Neurochem. 2009, 111:1129-1137.
28. Lendvai B., Vizi E.S. Nonsynaptic chemical transmission through nicotinic acetylcholine receptors. Physiol. Rev. 2008, 88:333-349.
29. Liu S.J., Fang Z.Y., Yang Y., Deng H.M., Wang J.Z. Alzheimer-like phosphorylation of tau and neurofilament induced by cocaine in vivo. Acta Pharmacol. Sin. 2003, 24:512-518.
30. Narayana P.A., Ahobila-Vajjula P., Ramu J., Herrera J., Steinberg J.L., Moeller F.G. Diffusion tensor imaging of cocaine-treated rodents. Psychiatry Res. 2009, 171:242-251.
31. Nixon R.A. The slow axonal transport of cytoskeletal proteins. Curr. Opin. Cell Biol. 1998, 10:87-92.
32. Pontieri F.E., Tanda G., Di C.G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the " shell" as compared with the " core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:12304-12308.
33. Rao M.V., Engle L.J., Mohan P.S., Yuan A., Qiu D., Cataldo A., Hassinger L., Jacobsen S., Lee V.M., Andreadis A., Julien J.P., Bridgman P.C., Nixon R.A. Myosin Va binding to neurofilaments is essential for correct myosin Va distribution and transport and neurofilament density. J. Cell Biol. 2002, 159:279-290.
34. Ratnam J., Teichberg V.I. Neurofilament-light increases the cell surface expression of the N-methyl-d-aspartate receptor and prevents its ubiquitination. J. Neurochem. 2005, 92:878-885.
35. Rossi S., Singer S., Shearman E., Sershen H., Lajtha A. Regional heterogeneity of nicotine effects on neurotransmitters in rat brains in vivo at low doses. Neurochem. Res. 2005, 30:91-103.
36. Sandor N.T., Zelles T., Kiss J., Sershen H., Torocsik A., Lajtha A., Vizi E.S. Effect of nicotine on dopaminergic-cholinergic interaction in the striatum. Brain Res. 1991, 567:313-316.
37. Sbarbati A., Bunnemann B., Cristofori P., Terron A., Chiamulera C., Merigo F., Benati D., Bernardi P., Osculati F. Chronic nicotine treatment changes the axonal distribution of 68kDa neurofilaments in the rat ventral tegmental area. Eur. J. Neurosci. 2002, 16:877-882.
38. Sershen H., Balla A., Lajtha A., Vizi E.S. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience 1997, 77:121-130.
39. Shen H.W., Toda S., Moussawi K., Bouknight A., Zahm D.S., Kalivas P.W. Altered dendritic spine plasticity in cocaine-withdrawn rats. J. Neurosci. 2009, 29:2876-2884.
40. Shoop R.D., Yamada N., Berg D.K. Cytoskeletal links of neuronal acetylcholine receptors containing alpha 7 subunits. J. Neurosci. 2000, 20:4021-4029.
41. Sperlagh B., Windisch K., Ando R.D., Sylvester V.E. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens. Neurochem. Int. 2009, 54:452-457.
42. Sun W.L., Zhou L., Quinones-Jenab V., Jenab S. Cocaine effects on dopamine and NMDA receptors interactions in the striatum of Fischer rats. Brain Res. Bull. 2009, 80:377-381.
43. Sziraki I., Sershen H., Benuck M., Hashim A., Lajtha A. Receptor systems participating in nicotine-specific effects. Neurochem. Int. 1998, 33:445-457.
44. Toda S., Shen H.W., Peters J., Cagle S., Kalivas P.W. Cocaine increases actin cycling: effects in the reinstatement model of drug seeking. J. Neurosci. 2006, 26:1579-1587.
45. Torocsik A., Oberfrank F., Sershen H., Lajtha A., Nemesy K., Vizi E.S. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur. J. Pharmacol. 1991, 202:297-302.
46. Toth E., Sershen H., Hashim A., Vizi E.S., Lajtha A. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem. Res. 1992, 17:265-271.
47. Veeranna, Grant P., Pant H.C. Expression of p67 (Munc-18), CDK5, P-NFH and syntaxin during development of the rat cerebellum. Dev. Neurosci. 1997, 19:172-183.
48. Villasana L.E., Klann E., Tejada-Simon M.V. Rapid isolation of synaptoneurosomes and postsynaptic densities from adult mouse hippocampus. J. Neurosci. Methods 2006, 158:30-36.
49. Wise R.A. Roles for nigrostriatal - not just mesocorticolimbic - dopamine in reward and addiction. Trends Neurosci. 2009, 32:517-524.